Atrial Late Gadolinium Enhancement in Patients with Repaired Congenital Heart Disease
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
In this research study the investigators want to learn more about how well the investigators can visualize scar tissue in the heart by MRI. In patients with congenital heart disease who need a procedure in the electrophysiology laboratory, how the MRI findings match the findings in the electrophysiology laboratory is not known. This study works to answer these questions. Participants will undergo a cardiac MRI as part of the routine clinical care that was ordered by their doctors and additional imaging by cardiac MRI will be performed.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 13
Healthy Volunteers: f
View:
• Patients \>13 years old with congenital heart disease referred for cardiac MRI and receiving gadolinium as part of routine clinical care or for pre-ablation planning will be included.
Locations
United States
Massachusetts
Boston Children's Hospital
RECRUITING
Boston
Contact Information
Primary
Daniel A Castellanos, MD
daniel.castellanos@cardio.chboston.org
6173557769
Backup
Edward O'Leary, MD
Edward.OLeary@cardio.chboston.org
6173557275
Time Frame
Start Date: 2022-03-23
Estimated Completion Date: 2029-06-30
Participants
Target number of participants: 50
Treatments
Patients with congenital heart disease undergoing a cardiac MRI with Gadolinium
Patients with congenital heart disease who are undergoing a clinically-ordered cardiac MRI and as part of that MRI the contrast agent, Gadolinium, will be administered.
Related Therapeutic Areas
Sponsors
Leads: Boston Children's Hospital